A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/2001
12/06/2001	CA2410900A1 Compositions and methods for treating eye discomfort
12/06/2001	CA2410889A1 Naaladase inhibitors for treating retinal disorders and glaucoma
12/06/2001	CA2410660A1 Cyclohexylamine derivatives as subtype selective nmda receptor antagonists
12/06/2001	CA2410655A1 Dihydropyridine compounds for the inhibition of calcium-influx
12/06/2001	CA2410618A1 S-methyl-dihydro-ziprasidone for treatment of psychiatric disorders
12/06/2001	CA2410084A1 Transporters and ion channels
12/06/2001	CA2409006A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists
12/05/2001	EP1160248A1 N-(Isoxazol-5-yl)-sulfonamide derivatives and their use as endothelin antagonists
12/05/2001	EP1160005A1 Nanoemulsion based on anionic polymers, and uses thereof especially in the cosmetic, dermatological, pharmaceutical and/or ophthalmic fields
12/05/2001	EP1159975A2 Anti-angiogenic compositions and methods of use
12/05/2001	EP1159974A1 Anti-angiogenic compositions and methods of use
12/05/2001	EP1159962A1 Liposome preparations
12/05/2001	EP1159420A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
12/05/2001	EP1159419A1 Promotion or inhibition of angiogenesis and cardiovascularization
12/05/2001	EP1159418A2 Muc-1 antagonists and methods of treating immune disorders
12/05/2001	EP1159288A1 Alpha-conotoxin peptides
12/05/2001	EP1159286A1 Tumor necrosis factor receptors 6 alpha and 6 beta
12/05/2001	EP1159284A1 33 human secreted proteins
12/05/2001	EP1159275A2 Imidazole compounds as histamine h3 ligands
12/05/2001	EP1159265A1 C-16 unsaturated fp-selective prostaglandins analogs
12/05/2001	EP1158984A1 Inhibitors of prenyl-protein transferase
12/05/2001	EP1158983A1 Inhibitors of prenyl-protein transferase
12/05/2001	EP1158982A2 Inhibitors of prenyl-protein transferase
12/05/2001	EP1158958A1 Improved powdery pharmaceutical compositions for inhalation
12/05/2001	EP0994693B1 Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin
12/05/2001	EP0941094B1 Process for manufacturing ophthalmic suspensions containing brinzolamide
12/05/2001	EP0937036B1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
12/05/2001	EP0862414B1 Ophthalmic compositions containing cyclodextrins and quaternary ammonium compounds
12/05/2001	EP0835263B1 Somatostatin peptides
12/05/2001	EP0789687B1 Ep2-receptor agonists as agents for lowering intraocular pressure
12/05/2001	EP0769056B1 NON-SPLICING VARIANTS OF gp350/220
12/05/2001	CN1325407A Platelet-derived growth factor D, DNA coding therefor and uses thereof
12/05/2001	CN1325393A Method for producing luteolin and luteolin derivatives
12/05/2001	CN1325384A Anthranilic acid amides and the use thereof as medicaments
12/05/2001	CN1325308A Use of neurotrophic factor stimulators for treatment of ophthalmic neurodegenerative diseases
12/05/2001	CN1324611A Eye medicine prepn. for computer eyesight syndrome and xerophthalmia
12/05/2001	CN1075816C Methods for in vivo reduction of nitric oxide levels and compositions sueful therefor
12/04/2001	US6326499 Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eye
12/04/2001	US6326398 Oxamic acids and derivatives as thyroid receptor ligands
12/04/2001	US6326389 Administering sodium channel modulators
12/04/2001	US6326019 Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
12/04/2001	US6326008 Toxoplasma gondii antigens, the preparation thereof and the use thereof
12/04/2001	CA2208836C Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
11/2001
11/30/2001	CA2348847A1 New isoxazole-sulfonamide endothelin antagonists
11/29/2001	WO2001090359A2 G-protein coupled receptors
11/29/2001	WO2001090334A2 Drug metabolizing enzymes
11/29/2001	WO2001090148A2 Neurotransmitter transporters
11/29/2001	WO2001090110A1 Macrolides
11/29/2001	WO2001090106A2 Tryasolyl tropane derivatives as ccr5 modulators
11/29/2001	WO2001090101A1 Arylmethylamine derivatives for use as tryptase inhibitors
11/29/2001	WO2001090100A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001	WO2001090094A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090093A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090092A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090091A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090090A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090086A1 A polymorph of 5-(4-aminosulfonyl-3-fluorophenyl)-4-cyclohexyl-2-methyloxazole
11/29/2001	WO2001090083A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists
11/29/2001	WO2001090076A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001	WO2001090074A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a)
11/29/2001	WO2001090070A2 Caspase inhibitors and uses thereof
11/29/2001	WO2001090063A2 Prodrug of an ice inhibitor
11/29/2001	WO2001090060A1 Disulfide derivatives useful for treating allergic diseases
11/29/2001	WO2001090059A1 Aniline disulfide derivatives for treating allergic diseases
11/29/2001	WO2001089816A1 Crystalline polymeric compositions for ophthalmic devices
11/29/2001	WO2001089578A1 Acetazolamide-based ophthalmic solution
11/29/2001	WO2001089533A2 Preparation for stabilizing the protective layer on the epithelium of the cornea or the alveoli
11/29/2001	WO2001089520A2 Dehydroascorbic acid formulations and uses thereof
11/29/2001	WO2001089492A1 Novel composition
11/29/2001	WO2001089451A2 Protease inhibitors
11/29/2001	WO2001089435A1 Methods of pre-selecting a polymerizable fluid formed into an intraocular lens
11/29/2001	WO2001049305A3 Process for obtaining thylakoids from plants, pure thylakoids and use thereof
11/29/2001	WO2001042471A8 Polypeptides and polynucleotides encoding same
11/29/2001	WO2001038566A3 Screening method for candidate drugs
11/29/2001	WO2001038347A3 Peptides having antiangiogenic activity
11/29/2001	WO2000055159A3 Substituted aza-oxindole derivatives
11/29/2001	WO2000039114A3 Substituted oximes and hydrazones as neurokinin antagonists
11/29/2001	WO2000034258A3 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
11/29/2001	US20010047018 Novel benzosultam oxazolidinone antibacterial agents
11/29/2001	US20010047008 Allosteric adenosine receptor modulators
11/29/2001	US20010047004 Oxazolidinone thioamides with piperazine amide substituents
11/29/2001	US20010046998 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
11/29/2001	US20010046993 5-memberd heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists
11/29/2001	US20010046987 Potent activity against Grampositive and Gramnegative bacteria
11/29/2001	US20010046982 Internal 1, 15-lactones of fluprostenol and related prostaglandin F2a analogs and their use in the treatment of glaucoma and intraocular hypertension
11/29/2001	DE10123349A1 New N-sulfonylated pipecolic acid derivatives, are matrix metalloprotease inhibitors useful e.g. for treating rheumatism, tumor progression, arteriosclerosis or inflammatory bowel disease
11/29/2001	CA2429199A1 Drug metabolizing enzymes
11/29/2001	CA2410294A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001	CA2408783A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	CA2408727A1 Benzophenones as inhibitors of il-1.beta. and tnf-.alpha.
11/29/2001	CA2408562A1 Dehydroascorbic acid formulations and uses thereof
11/29/2001	CA2408145A1 Aniline disulfide derivatives for treating allergic diseases
11/29/2001	CA2408141A1 Neurotransmitter transporters
11/29/2001	CA2408140A1 G-protein coupled receptors
11/29/2001	CA2407964A1 Disulfide derivatives useful for treating allergic diseases
11/29/2001	CA2407958A1 Crystalline polymeric compositions for ophthalmic devices
11/29/2001	CA2407780A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001	CA2406829A1 Protease inhibitors
11/29/2001	CA2380935A1 Caspase inhibitors and uses thereof
11/28/2001	EP1157992A1 Dihydro-2,3-Benzodiazepine derivatives

1 ... 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 ... 531